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Abstract: Pseudomonas aeruginosa, an important causative agent of nosocomial infection, is 
found throughout the hospital environment in moist reservoirs, and multidrug-resistant 
strains of P. aeruginosa have been increasingly reported worldwide. Bacteriophages are 
often considered potential therapeutic candidates in treating infectious diseases. In this 
study, a novel virulent bacteriophage φPA-HF17, specific infecting clinical isolates of   
P. aeruginosa, was isolated and characterized from environmental sewage. Transmission 
electron microscopy showed that phage φPA-HF17 had an icosahedral head with a very 
short tail, and exhibited characteristics typical of a podovirus. Restriction analysis indicated 
that phage φPA-HF17 was a double-stranded DNA virus, which might be digested by some 
restriction endonucleases. Phage φPA-HF17 was highly infectious with a rapid adsorption 
(>90% adsorbed in 4 min). In a one-step growth experiment, phage φPA-HF17 was shown 
having a latent period of 10 minute, with corresponding burst sizes of 200 PFU/cell. 
Furthermore, when φPA-HF17 alone was incubated at different pHs and different 
temperatures, the phage was stable over a wide pH range (4 to 10) and at extreme 
temperature (50°C). These results suggest that φPA-HF17 may be candidate therapeutic 
phage to control P. aeruginosa infection. 
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Introduction 
Pseudomonas aeruginosa is a facultatively anaerobic, non-fermentative, gram-negative, rod-
shaped bacterium very common in the hospital environment. This organism is an important 
causative agent of nosocomial and opportunistic infection in human, such as pneumonia, 
urinary tract infection, bacteremia, endocarditis, etc. [3, 21, 23]. Infections caused by   
P. aeruginosa are frequently life threatening in infants, elders and immunocompromised 
individuals [17]. In addition, P. aeruginosa, one of the most common multidrug-resistant 
(MDR) bacteria in hospitalized patients [13], routinely exhibits multiple mechanisms of drug-
resistance, for instance, efflux pumps, antibiotic degrading or modifying enzymes, and limited 
membrane permeability [12, 19]. Therefore, the declining efficacy of antibiotic therapy 
triggers the development of novel therapeutics for P. aeruginosa infections.    INT. J. BIOAUTOMATION, 2014, 18(3), 241-250 
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Bacteriophages are viruses that specifically infect and kill bacteria. Bacteriophage (phage) 
therapy is one of several potential therapeutic approaches against bacterial infections.   
There are at least two aspects in supporting the application of phage therapy: (1) it has been 
used for decades in Eastern Europe [20]; (2) much more biological properties of phages have 
been achieved [11, 16]. Currently, several papers have been published on the use of phages as 
specific antimicrobial agents [1, 4, 5]. For therapeutic purposes, virulent or lytic 
bacteriophages are highly desirable due to their ability to kill target host cells.  
 
In this study, clinical isolates of P. aeruginosa were collected and used as target cells to 
screen lytic phages from swage. A novel lytic phage (designated φPA-HF17) specifically 
infecting P. aeruginosa isolates was isolated and characterized. Its basic biological features 
including morphology, one-step growth, adsorption rate, pH and thermal stability were 
investigated. 
 
Materials and methods 
Bacterial strains, growth conditions and identification 
Nine clinical isolates of P. aeruginosa, previously isolated at Department of Clinical 
Laboratory, the third affiliated hospital of Jilin University, were used for phage isolation and 
identification. The VITEK system (bioMérieux, Craponne, France) was employed to identify 
the bacterial isolates using the Gram-negative bacterial identification cards. Clinical isolates 
of  P. aeruginosa were further confirmed by sequencing the 16S rRNA gene. Universal 
primers, 185f (5’ TAG TTG GTG GGG TAA AGG C 3’) and 705r (5’ TTT CGC ACC TCA 
GTG TCA G 3’), were adopted to amplify the partial 16S rRNA gene. Sequences of partial 
16S rRNA gene were deposited in GeneBank under accession number AF094715.   
All bacterial strains were grown on Nutrient agar and Luria-Bertani (LB) broth at 37°C. 
Bacterial growth was monitored turbidimetrically at OD600 of 0.4 (corresponded to   
3×10
8 cells/ml). 
 
Isolation of bacteriophages 
Procedure of phage isolation was conducted as previous description [10, 25]. Several 
specimens from raw sewage were collected and were immediately brought to the laboratory 
and centrifuged at 10,000 × g for 15 min at 4°C to remove debris. The supernatants were 
filtered through 0.45-μm-pore-size membranes (Millipore, Bedford, MA, USA). The filtrate 
was added to a fresh bacterial culture in LB. The mixture was incubated at 37°C for 8 h at 
150 rpm, then centrifuged at 10,000 × g for 15 min and filtered through a 0.2-μm-pore-size 
membrane (Millipore). The filtrated supernatant was used to check the presence of lytic 
phages by the double-layer method [27] using Nutrient agar as the culture medium. The plate 
were incubated at 37°C and examined for the presence of plaques after 12 h. A pure phage 
stock was achieved through purified plaque using three consecutive round of single-plaque 
isolation. Phage stocks were stored at 4°C with 1% chloroform. 
 
Preparation of phage for Transmission Electron Microscopy (TEM) 
Morphology of purified phage particles was examined by transmission electron microscope of 
negatively stained preparations. Ten μl of phage particles (10
10 PFU/ml) was spotted onto a 
400-mesh-size formvar-carbon-coated copper grid, stained with 2% uranyl acetate and then 
examined by Hitachi TEM system with an accelerating voltage of 80 kV.  
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Extraction of phage DNA and restriction analysis 
Phage particles were precipitated with polyethylene glycol (PEG), followed by 10,000 × g for 
15 min. Pellets were resuspended in TE buffer and the procedure for extraction of phage DNA 
was carried out as previously described [27]. Phage genomic DNA was subjected to 
restriction digestion with nine restriction enzymes (Nde I, Bgl II, Xho I, Xba I, Not I, Pst I, 
EcoR V, Hind III, and EcoR I). The digested products were analyzed by agarose gel 
electrophoresis.  
  
Adsorption rate and one-step growth assay 
Procedures for adsorption rate were conducted by standard method [9]. Briefly, phages were 
mixed with 10 ml of mid-exponential host cells at multiplicity of infection (MOI) of 0.01.  
The mixture was incubated at 37°C at 150 rpm. At 1 min intervals for 10 min, 100 μl of 
sample was mixed with 450 μl SM buffer (50 mM Tris-Cl, pH 7.5, containing 0.58% NaCl 
and 0.2% MgSO4) and 50 μl chloroform. The mixture was centrifuged at 10,000 × g for  
6 min, and the percentage of unadsorbed phage in each sample was measured by the double-
layer method. 
 
For one-step growth experiments, 50 ml bacterial cells were incubated to mid-exponential 
phase and harvested by centrifugation. The pellet was resuspended in 20 ml of fresh LB 
medium. Phage solution was added to the bacterial suspension at a MOI of 0.01 and allowed 
to adsorb for 5 min. The mixture was continuously incubated at 37°C. Samples were taken at 
10 min intervals and phage titer was determined by the double-layer method. Finally, one-step 
growth curve was deduced according to the constant phage titer.  
 
Analysis of phage proteins 
Phage solution was subjected to Amicon-100 filter, and the phage particles were washed three 
times with SM buffer. Purified phage particles were mixed with sample buffer and heated 
in  a  boiling water bath for 6 min. A volume of purified viral particles corresponding to 
10
12 PFU/ml was loaded directly onto a 12.5% SDS-PAGE for 2 h. Gels were stained with 
0.1% Coomassie brilliant blue and documented using gel image system.   
 
pH and thermal stability test 
Resistance to different pH values at 37°C was carried out as previously documented [22]. 
Briefly, the pH of the LB was adjusted with either 1 M HCl or 0.5 M NaOH to obtain a pH 
ranging from 1 to 14. A total of 100 μl of bacteriophage suspension (5×10
8 PFU/ml) was 
innoculated into 5 ml of pH-adjusted medium. After incubation for 1 h at 37°C, the surviving 
phage particles were counted immediately using the double-layer method. Thermal stability of 
phage at different temperatures (50°C, 60°C, 70°C and 80°C) was determined by incubating 
the phage (10
7 PFU/ml) at the indicated temperature for 30 min and 60 min at pH 7.0 in 
nutrient broth; the surviving phages were then calculated.  
 
Results 
Identification of P. aeruginosa clinical strains 
As described in Material and Methods, DNA fragment containing 16S rRNA gene from each 
clinical isolates was amplified by PCR and sequenced. PCR products were subjected to 
electrophoretic analysis, and the size of amplified DNA was 521 bp approximately (not 
shown). The sequences of PCR products were deposited to GeneBank and aligned to search 
for the most similar sequences. The results showed that the sequence of nine clinical isolates   INT. J. BIOAUTOMATION, 2014, 18(3), 241-250 
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was consistent with that of P. aeruginosa ATCC15692. Therefore, nine clinical isolates were 
validated to be P. aeruginosa. 
 
Morphology of bacteriophages φPA-HF17 revealed by TEM 
Using the described enrichment method, a lytic bacteriophage, designated as φPA-HF17, was 
isolated from raw sewage. This phage formed clear plaques of approximately 2-4 mm in 
diameter on P. aeruginosa lawns. Images of bacteriophage φPA-HF17 were developed using 
TEM. As shown in Fig. 1, the phage φPA-HF17 had an icosahedral head, about 50 nm in 
diameter, and a short non-contractile tail. Thus, phage φPA-HF17 was morphological similar 
to phages belonging to the Podoviridae family, Caudovirales order.  
 
   
 
Fig. 1 Transmission electron micrograph of phage φPA-HF17 
(an arrow indicates the short non-contract tail of phage, Bar corresponds to 100 nm) 
 
Restriction analysis of phage φPA-HF17 genome 
After enrichment of phage φPA-HF17, phage DNA was extracted and purified as described. 
Genomic DNA was cut by 9 restriction endonucleases. The results showed that the   
φPA-HF17 DNA was cut by Nde  I,  Xho I, Xba I, Pst I, Hind III and EcoR I (Fig. 2).   
The restriction analysis also demonstrated that phage φPA-HF17 was a dsDNA virus. 
Determination of the phage genome sequence is also underway. 
 
Adsorption rate and one-step growth curve of phage φPA-HF17 
The phage exhibited rapid adsorption onto the host cells as shown in Fig. 3. More than 90% 
of the phage particles were adsorbed in 4 min. A one-step growth experiment was carried out 
to determine the latent period and burst size of phage φPA-HF17. The latent period (defined 
as the time interval between the adsorption and the beginning of the first burst) was 10 min, 
and the burst size was 200 PFU/infected cell (Fig. 4).  
 
Analysis of phage proteins by SDS-PAGE 
SDS-PAGE analysis of phage φPA-HF17 revealed that three major proteins and at least   
8 minor proteins were observed on the gel, with molecular weight ranging from10 to 170 
kilodalton (Fig. 5). In the Fig. 5 Lane 1, PageRuler Prestained Protein Ladder #26617 
(Thermo); Lane 2 and Lane 3, Phage φPA-HF17 (10
12 PFU/ml). Three major structural 
proteins, with molecular weight ranging from 35 to 40 kilodalton, were found. 
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Fig. 2 Restriction analysis of phage φPA-HF17 genome 
M: DNA marker; Lane 1: DNA genome; Lane 2: Digestion of DNA with Nde I;  
Lane 3: Digestion of DNA with Bgl II; Lane 4: Digestion of DNA with Xho I;  
Lane 5: Digestion of DNA with Xba I; Lane 6: Digestion of DNA with Not I;  
Lane 7: Digestion of DNA with Pst I; Lane 8: Digestion of DNA with EcoR V;  
Lane 9: Digestion of DNA with Hind III; Lane 10: Digestion of DNA with EcoR I 
 
 
Fig. 3 Adsorption of phage φPA-HF17 to P. aeruginosa 
 
 
Fig. 4 One-step growth curve of phage φPA-HF17 on P. aeruginosa   INT. J. BIOAUTOMATION, 2014, 18(3), 241-250 
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Stability investigation 
As shown in Fig. 6, no obvious effect on φPA-HF17 activity was observed after 1 hour of 
incubation at pH levels ranging from 5 to 10. However, the phage φPA-HF17 completely lost 
its activity at pH 11 or higher and pH 3 or lower. When incubation at pH 4 for 1 h, a titer of 
1.37×10
4 PFU/ml of active phage φPA-HF17 was detected at the end of the incubation.   
The maximum stability of the phage was observed at a pH 5, 6, 7, 8, and 9. Heat resistant 
capability of phage φPA-HF17 at pH7.0 was performed. The results showed that φPA-HF17 
was extremely heat stable (Fig. 7); nearly 100% phage particles (10
7 PFU/ml) remained alive 
after 30 min and 60 min at 50°C, however, the number of viable phages decreased from  
10
7 PFU/ml to both10
6 PFU/ml after 30 min and 4.5×10
6 PFU/ml after 60 min at 60°C, 
respectively.  
 
Fig. 5 SDS-PAGE analysis of 
phage φPA-HF17 proteins.  
Fig. 6 pH stability test of phage φPA-HF17 
 
 
Fig. 7 Heat stability test of phage φPA-HF17   INT. J. BIOAUTOMATION, 2014, 18(3), 241-250 
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Discussion 
The search for potential therapeutic phages against P. aeruginosa has regained much attention 
because of the increasing prevalence of metallo-β-lactamase and 16S rRNA methylase 
coproducing P. aeruginosa strains associated with human infections [7]. Bacteriophages are 
thought to be the most abundant microorganisms on the earth [8, 24], whose total count is 
estimated to be more than 10
30 [18]. As ubiquitous, they can be found in varies types of water 
and soils as well as in gastrointestinal tract of animals. Recently, a few publications have 
documented the efficacy of bacteriophage agents in eliminating clinical P. aeruginosa isolates 
both in vitro and in vivo [6, 15, 26]. In this study, phage φPA-HF17 specific to P. aeruginosa 
was isolated and characterized from swage.  
 
Bacteriophages of P. aeruginosa, belonging to tailed virus with double stranded DNA 
genome, are classified into three families of the order of Caudovirales, including Myoviridae, 
Podoviridae, and Siphoviridae [14]. Among the tailed phages of the genus Pseudomonas, 
there are about 36% from the family Myoviridae, the same percentage from the family 
Siphoviridae and 28% belonging Podoviridae [2]. Our results showed that phage φPA-HF17 
had an icosahedral head with a very short tail, and the size of its head was 50 nm in diameter, 
approximately. Based on its morphological features, phage φPA-HF17 was tentatively 
classified as a member of Podoviridae family. To the best of our knowledge, other researchers 
had reported isolation of the P. aeruginosa specific phages belonging to families Podoviridae 
and  Siphoviridae [10]. Purified virion DNA was digested with several restriction 
endonuclease and subsequently subjected to electrophoresis analysis. The results showed that 
the φPA-HF17 DNA was cut by 6 of the 9 enzymes, including Nde I, Xho I, Xba I, Pst I,  
Hind III and EcoR I. With respect to one-step growth assay, latent period and burst size are 
the parameter used to measure phage infectivity. In this study, phage φPA-HF17 proliferates 
efficiently with a relatively short latent period (10 min) and a large burst size (200 PFU/cell). 
Furthermore, φPA-HF17 adsorbs more rapidly (> 90% adsorbed in 4 min). Hence, φPA-HF17 
could be considered as a candidate for phage therapy, as it has rapid adsorption rate and 
efficient proliferation at 37°C. In addition, pH stability showed that no reduction of phage 
φPA-HF17 was observed when incubation at pH 5, 6, 7, 8, 9 and 10. Therefore, φPA-HF17 
was stable over a wide pH range (5 to 10). All of these characteristics have implications for 
the use of this phage as a stable antimicrobial agent for the treatment of P. aeruginosa 
infections.  
 
Conclusion 
In this study, a lytic phage of P. aeruginosa, φPA-HF17, was characterized, combined with its 
efficient in lysing P. aeruginosa isolates and its pH stability, it may be a good candidate to be 
used as an alternative agent against P. aeruginosa infections.  
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